Merck Donates over $125,000 to the West Island Community
KIRKLAND, QC, Oct. 31, 2017 /CNW Telbec/ - On October 30th, Merck Canada Inc.'s President Chirfi Guindo presented a cheque totalling more than $125,000 for the International Neighbour of Choice award at a "masquerade" celebration held at the company's head office in Kirkland. This year's recipients, The West Island Palliative Care Residence, NOVA West Island and West Island Community Shares, were honoured for the positive impact they have made in the West Island. The Merck International Neighbour of Choice program is designed to support the outstanding work by non-profit organizations whose mission is to improve the quality of life of people and preserve the environment in the communities where Merck operates. From left to right: Mr. Geoffrey Kelley, Member of the National Assembly for Jacques-Cartier, Minister responsible for Native Affairs; Ms. Leanne Bayer, Executive Director, West Island Community Shares; Ms. Teresa Dellar, Executive Director and Co-Founder, West Island Palliative Care Residence; Ms. Marie-France Juneau, Executive Director, NOVA West Island; and Mr. Chirfi Guindo, President and Managing Director, Merck Canada Inc.
The revenue in April for Zinzino's sales markets increased by 34 % and amounted to SEK 155.7 (116.0) million. Faun Pharma's external sales increased by 54 % and amounted to SEK 8.0 (5.2) million. Overall, the Group increased revenues by 35 % to SEK...
Nearly all American adults (95%) agree stroke is an emergency, yet according to new omnibus survey by The Harris Poll on behalf of the Get Ahead of Stroke® campaign, less than half (43%) say they would call 911 if they were experiencing a common...
Pan-Canadian children's health advocate Children's Healthcare Canada is calling on the federal government to show political will to solve the crises plaguing children's healthcare and declare children's health and well-being a national priority. ...
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global...
Lantern Pharma Inc. , a leading artificial intelligence (AI) oncology drug discovery and development company, today announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimize the development of...
